Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time-Reference-Cited by-同舟云学术

Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time

Published:2016-07-01 Issue:4 Volume:1 Page:451
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Hijazi Ziad¹,Hohnloser Stefan H.²,Andersson Ulrika³,Alexander John H.⁴,Hanna Michael⁵,Keltai Matyas⁶,Parkhomenko Alexander⁷,López-Sendón José L.⁸,Lopes Renato D.⁴,Siegbahn Agneta⁹,Granger Christopher B.⁴,Wallentin Lars¹

Affiliation:

1. Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden2Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

2. J. W. Goethe University, Frankfurt, Germany

3. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

4. Duke Clinical Research Institute, Duke Medicine, Durham, North Carolina

5. Bristol-Myers Squibb, Princeton, New Jersey

6. Hungarian Institute of Cardiology, Semmelweis University, Budapest, Hungary

7. Institute of Cardiology, Kiev, Ukraine

8. Hospital Universitario La Paz, IdiPaz, Madrid, Spain

9. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden9Department of Medical Sciences, Clinical Chemistry, Uppsala University, Uppsala, Sweden

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation in Chronic Kidney Disease;Drugs;2024-08-09

2. Apixaban Use in Patients with Kidney Impairment: A Review of Pharmacokinetic, Interventional, and Observational Study Data;American Journal of Cardiovascular Drugs;2024-08-05

3. Adverse events of direct factor Xa inhibitors: a disproportionality analysis of the FAERS database;Expert Opinion on Drug Safety;2024-06-18

4. Incidence and Predictors of Worsening Renal Function in Edoxaban-Treated Atrial Fibrillation Patients Within ETNA-AF-Europe Registry;JACC: Advances;2024-04

5. Atrial fibrillation: comorbidities, lifestyle, and patient factors;The Lancet Regional Health - Europe;2024-02